Eva J. Vlug - Concepedia

Author

Eva J. Vlug

University Medical Center Utrecht

Also Known As

E J Vlug, Eva J Vlug, Eva J. Vlug, Eva Johanneke Vlug, Eva Vlug

Publications

462

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht The Netherlands Cancer Institute Radboud University Nijmegen Oncode Institute Utrecht University

About

Eva J. Vlug is an author at University Medical Center Utrecht specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	190
2	Cell Biology	4	4	190
3	Cancer Cell Biology	3	3	176
4	Health Sciences	1	1	14
5	Pathology	1	1	48

Eva J. Vlug

Publications

430

Citations

H-Index

Page 1

	Year	Citations
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance Ron C.J. Schackmann, Miranda van Amersfoort, Judith H.I. Haarhuis, Journal of Clinical Investigation	2011	143
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer Eva J. Vlug, Robert A. H. van de Ven, Jeroen F. Vermeulen, Cellular Oncology	2013	76
FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance Iordanka A. Ivanova, Jeroen F. Vermeulen, Cihangir Mutlu Ercan, Oncogene Breast Cancer MetastasisBreast Cancer GrowthBreast OncologyCell AdhesionHormone Receptor Antagonists	2013	70
Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling Ron C.J. Schackmann, Sjoerd Klarenbeek, Eva J. Vlug, Cancer Research Metastatic Breast CancerAnoikis ResistanceBreast OncologySomatic LossConditional Mouse Model	2013	58
αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer Jolien S. de Groot, Max A. K. Rätze, Miranda van Amersfoort, The Journal of Pathology Breast OncologyAnchorage IndependencePathologyCandidate Tumor SuppressorCancer Biology	2018	48
Controlling Cardiomyocyte Survival Nicolaas de Jonge, Marie‐José Goumans, Daan J. Lips, Novartis Foundation symposium Signalling PathwaysCardiomyopathyHeart FailureSignal TransductionCardiac Muscle	2006	14
Intraductal cisplatin treatment in a <i>BRCA</i>-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice Jolien S. de Groot, P. J. van Diest, Miranda van Amersfoort, Oncotarget	2017	11
Methylation biomarkers for pleomorphic lobular breast cancer - a short report Cathy B. Moelans, Eva J. Vlug, Cigdem Ercan, Cellular Oncology	2015	10

Page 1